ES2145118T3 - Derivados de acidos grasos y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de acidos grasos y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2145118T3
ES2145118T3 ES94903364T ES94903364T ES2145118T3 ES 2145118 T3 ES2145118 T3 ES 2145118T3 ES 94903364 T ES94903364 T ES 94903364T ES 94903364 T ES94903364 T ES 94903364T ES 2145118 T3 ES2145118 T3 ES 2145118T3
Authority
ES
Spain
Prior art keywords
derivatives
fatty acids
pharmaceutical compositions
contain
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94903364T
Other languages
English (en)
Inventor
William A Devane
Raphael Mechoulam
Aviva Beuer
Lumir Hanus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Application granted granted Critical
Publication of ES2145118T3 publication Critical patent/ES2145118T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

AMIDAS DE ACIDOS GRASOS POLIINSATURADOS PUROS Y SUS DERIVADOS. ESTOS COMPUESTOS PRODUCIDOS SINTETICAMENTE SON CAPACES DE IMITAR DE FORMA NATURAL LA OCURRENCIA DE LAS ANANDAMIDAS EN LA MENTE Y UNIR EL RECEPTOR CANABINOIDE. LOS COMPUESTOS EXHIBEN ACTIVIDAD FISIOLOGICA Y SON UTILES COMO INGREDIENTES ACTIVOS EN COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE INFLAMACION, MIGRAÑAS, ACTIVIDAD DE ESPECTICIDAD, GLAUCOMA, ESCLEROSIS MULTIPLE. LOS COMPUESTOS ACTIVOS PUEDEN PROPORCIONARSE EN FORMA DE ISOTOPO MARCADO.
ES94903364T 1992-11-30 1993-11-30 Derivados de acidos grasos y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2145118T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10393292A IL103932A (en) 1992-11-30 1992-11-30 Fatty acid and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ES2145118T3 true ES2145118T3 (es) 2000-07-01

Family

ID=11064282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94903364T Expired - Lifetime ES2145118T3 (es) 1992-11-30 1993-11-30 Derivados de acidos grasos y composiciones farmaceuticas que los contienen.

Country Status (13)

Country Link
EP (1) EP0670826B1 (es)
JP (1) JPH08504195A (es)
CN (1) CN1097735A (es)
AU (1) AU5733494A (es)
CZ (1) CZ136195A3 (es)
DE (1) DE69328492T2 (es)
ES (1) ES2145118T3 (es)
HU (1) HUT73177A (es)
IL (1) IL103932A (es)
PL (1) PL309051A1 (es)
SK (1) SK70895A3 (es)
WO (1) WO1994012466A1 (es)
ZA (1) ZA938947B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
WO1996001558A1 (en) * 1994-07-11 1996-01-25 Pate David W Anandamide analogue compositions and method of treating intraocular hypertention using same
IT1271267B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
DE19544635A1 (de) * 1995-11-30 1997-06-05 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
WO1999051560A1 (en) * 1998-04-03 1999-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Synthetic endogenous cannabinoids analogues and uses thereof
EP1645270B1 (en) * 1998-05-29 2010-04-28 Neurosciences Research Foundation Inc. Control of pain with ANANDAMIDE
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
CA2635412C (en) 1998-08-17 2011-06-21 Senju Pharmaceutical Co., Ltd. Agent for prophylaxis and treatment of asthenopia or pseudomyopia
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
AU1833600A (en) * 1998-11-24 2000-06-19 Andreas Goutopoulos Cannabimimetic lipid amides as useful medications
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7393842B2 (en) 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US6974568B2 (en) 2000-05-23 2005-12-13 The Regents Of The University Of California Treatment for cough
NO20006008L (no) * 2000-11-28 2002-05-29 Thia Medica As Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
CA2435409A1 (en) 2001-01-26 2002-08-01 University Of Connecticut Novel cannabimimetic ligands
KR20030087657A (ko) 2001-03-27 2003-11-14 더 리전츠 오브 더 유니버시티 오브 캘리포니아 체지방 감소 및 지방산 대사 조절을 위한 방법, 화합물 및조성물
EP1414775B1 (en) 2001-07-13 2012-12-19 The University of Connecticut Bicyclic cannabinoid
WO2003008632A1 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Fatty acid conjugation as a method for screening of potentially bioactive substances
CA2478338A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
WO2004103410A1 (en) 2002-06-06 2004-12-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods compositions and articles of manufacture for modulating bone growth
ITMI20030210A1 (it) * 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L Composti endocannabinoido-simili e loro impiego
US7276608B2 (en) 2003-07-11 2007-10-02 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives as cannabinoid receptor modulators
US7326706B2 (en) 2003-08-15 2008-02-05 Bristol-Myers Squibb Company Pyrazine modulators of cannabinoid receptors
IL160420A0 (en) 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
CA2650900A1 (en) * 2006-05-01 2007-11-15 Eastern Virginia Medical School Novel cannabinoids and methods of use
WO2008139263A2 (en) * 2006-11-30 2008-11-20 University Of Plymouth Methods for slowing the progression of multiple sclerosis
ES2534900T3 (es) 2007-07-30 2015-04-30 Zynerba Pharmaceuticals, Inc. Profármacos de cannabidiol, composiciones que comprenden los profármacos de cannabidiol y métodos de uso de los mismos
EP2262763A2 (en) 2008-03-04 2010-12-22 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compounds and methods of treating obesity
WO2010013240A1 (en) * 2008-07-31 2010-02-04 Dekel Pharmaceuticals Ltd. Compositions and methods for treating inflammatory disorders
ES2549924T3 (es) * 2009-11-25 2015-11-03 Cytometix, Inc. Análogos de ácido araquidónico y métodos para tratamiento analgésico usando el mismo
CN103877100B (zh) * 2013-05-21 2016-08-10 成都旗美健康食品有限公司 亚麻酸酰基乙醇胺的联合医用和保健用药物
AU2020260090C9 (en) 2019-04-15 2023-08-31 Metagenics LLC Novel hemp and PEA formulation and its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE306730B (es) * 1963-02-06 1968-12-09 Sumitomo Chemical Co
SE353319B (es) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
US4619938A (en) * 1984-03-21 1986-10-28 Terumo Kabushiki Kaisha Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet aggregation inhibitors
NZ216751A (en) * 1985-07-05 1990-01-29 Cird Eicosatriynoic acid esters and amides,pharmaceutical compositions and process for preparing eicosatriynoic acid

Also Published As

Publication number Publication date
CZ136195A3 (en) 1995-11-15
EP0670826A4 (en) 1996-08-14
CN1097735A (zh) 1995-01-25
WO1994012466A1 (en) 1994-06-09
HU9501561D0 (en) 1995-07-28
SK70895A3 (en) 1995-09-13
IL103932A (en) 1997-02-18
JPH08504195A (ja) 1996-05-07
HUT73177A (en) 1996-06-28
ZA938947B (en) 1994-08-02
DE69328492T2 (de) 2000-09-07
EP0670826B1 (en) 2000-04-26
IL103932A0 (en) 1993-04-04
AU5733494A (en) 1994-06-22
DE69328492D1 (de) 2000-05-31
PL309051A1 (en) 1995-09-18
EP0670826A1 (en) 1995-09-13

Similar Documents

Publication Publication Date Title
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2058109T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica antimicrobiana topica.
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES2036593T3 (es) Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
ES2136100T3 (es) Composicion lipida para productos cosmeticos que contienen trigliceridos de acidos grasos insaturados.
ES2133575T3 (es) Grasas para untar beneficiosas para la salud.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2153053T3 (es) Liposomas de eter-lipido y su uso terapeutico.
ES2174080T3 (es) Vehiculos de principios activos a base de agentes tensioactivos no ionicos y sus aplicaciones particularmente en los ambitos alimentario, cosmetico y farmaceutico.
ATE82684T1 (de) Mittel zur behandlung und zum schutz der haut.
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
ES2003605A6 (es) Procedimiento de obtencion de una composicion farmaceutica particularmente dermatologica o cosmetica a base de fases laminares lipidicas hidratas o de liposomas que contienen un retinoide o un analogo estructural de dicho retinoide tal como un carotenoide.
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
MX9303799A (es) Derivados de la serie de vitamina d con modificaciones en la posicon 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la prod.
ES2171933T3 (es) Derivados de androsteno.
ES2033985T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
ES2137694T3 (es) Sales de metales pesados de los semiesteres del acido succinico con el acido hialuronico, o con los esteres del acido hialuronico. un proceso para la preparacion y composiciones farmaceuticas relacionadas.
NZ308293A (en) Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
AR037766A1 (es) Compuestos triaromaticos analogos de la vitamina d, su utilizacion, composiciones farmaceuticas y cosmeticas que los comprenden y utilizacion cosmetica de dichas composiciones cosmeticas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 670826

Country of ref document: ES